{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:45Z","timestamp":1791828585484,"version":"4.3.4"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"6","funder":[{"DOI":"10.13039\/100018935","name":"Lin He's New Medicine and Clinical Translation Academician Workstation Research Fund","doi-asserted-by":"crossref","award":["17331210"],"award-info":[{"award-number":["17331210"]}],"id":[{"id":"10.13039\/100018935","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"crossref","award":["Y20170135"],"award-info":[{"award-number":["Y20170135"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2019-0376_abs_001_w2aab3b7c12b1b6b1aab1c15b2Aa\">\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Marked hypertriglyceridemia in infancy is extremely rare. Patients with severe hypertriglyceridemia in early life may be unmasked by a primary or secondary cause.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0376_abs_002_w2aab3b7c12b1b6b1aab1c15b3Aa\">\n                  <jats:title>Case presentation<\/jats:title>\n                  <jats:p>A female infant was born in a good condition with normal Apgar scores. No special clinical symptoms and signs had been found within the first two months of life. Poor oral intake and failure to thrive were two main clinical manifestations when she was referred to our hospital at the age of 3.5\u00a0months. The milky serum was the only one characteristic presentation. Laboratory testing showed extremely high level of triglycerides, cholesterol and lactate. Many other laboratory indexes cannot be detected because of severe hyperlipemic samples. Multi-gene panel testing for 249 genes about genetic and metabolic liver disease were performed. Gene analysis revealed a G6PC gene deficiency. The patient was a homozygote for c.248G\u00a0&gt;\u00a0A, p.R83H and her parents were both the heterozygotes. The infant had been diagnosed as glycogen storage disease type Ia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0376_abs_003_w2aab3b7c12b1b6b1aab1c15b4Aa\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We report an infant presenting with extreme hypertriglyceridemia diagnosed as glycogen storage disease type Ia by genetic testing. The gene panel can be used to confirm the diagnosis and delineate the exact type of glycogen storage disease, which could ultimately really help to reduce unnecessary tests and invasive examinations. Serum lipid should be close monitoring in order to prevent the complications and improve the prognosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2019-0376","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T16:36:11Z","timestamp":1590510971000},"page":"803-808","source":"Crossref","is-referenced-by-count":4,"title":["An infant presenting with extreme hypertriglyceridemia diagnosed as glycogen storage disease type Ia"],"prefix":"10.1515","volume":"33","author":[{"given":"Ling-Juan","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Pediatric Gastroenterology , The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , 109 Xueyuan Western Road , Wenzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuerbanjiang","family":"Abuduxikuer","sequence":"additional","affiliation":[{"name":"The Center for Pediatric Liver Disease , Children's Hospital of Fudan University , 399 Wanyuan Road , Minhang District , Shanghai , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Mei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology , The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , 109 Xueyuan Western Road , Wenzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology , The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , 109 Xueyuan Western Road , Wenzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology , The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University , 109 Xueyuan Western Road , Wenzhou , Zhejiang Province , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"2023040101344807837_j_jpem-2019-0376_ref_001_w2aab3b7c12b1b6b1ab2b1b1Aa","unstructured":"Bali DS, Chen YT, Austin S, Goldstein JL. Glycogen Storage Disease Type I. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReview. Seattle (WA): University of Washington, Seattle 1993\u22122017."},{"key":"2023040101344807837_j_jpem-2019-0376_ref_002_w2aab3b7c12b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Melis D, Cozzolino M, Minopoli G, Balivo F, Parini R,  et al. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study. J.\u00a0Pediatr 2015;166:1079\u201382. https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.015.","DOI":"10.1016\/j.jpeds.2014.12.015"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_003_w2aab3b7c12b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"de Ferranti SD, Crean S, Cotter J, Boyd D, Osganian SK. Hypertriglyceridemia in a pediatric referral practice: experience with 300 patients. Clin Pediatr (Phila) 2011;50:297\u2013307. https:\/\/doi.org\/10.1177\/0009922810379498.","DOI":"10.1177\/0009922810379498"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_004_w2aab3b7c12b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J,  et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients\u00a0with severe hypertriglyceridaemia. J Intern Med 2012;272:185\u201396. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02516.x.","DOI":"10.1111\/j.1365-2796.2012.02516.x"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_005_w2aab3b7c12b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Hwu WL, Chuang SC, Tsai LP, Chang MH, Chuang SM,  et al. Glucose-6-phosphatase gene G327A mutation is common in Chinese patients with glycogen storage disease type Ia. Hum Mol Genet 1995;4:1095\u20136. https:\/\/doi.org\/10.1093\/hmg\/4.10.2006.","DOI":"10.1093\/hmg\/4.6.1095"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_006_w2aab3b7c12b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Chou JY, Mansfield BC. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum Mutat 2008;29:921\u201330. https:\/\/doi.org\/10.1002\/humu.20772.","DOI":"10.1002\/humu.20772"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_007_w2aab3b7c12b1b6b1ab2b1b7Aa","unstructured":"Scriver CR, Valle D, Beaudet L, Vogelstein B, Kinzler KW, et al. The Online Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill Education."},{"key":"2023040101344807837_j_jpem-2019-0376_ref_008_w2aab3b7c12b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161:S20\u201334. https:\/\/doi.org\/10.1007\/s00431-002-0999-4.","DOI":"10.1007\/BF02679990"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_009_w2aab3b7c12b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Peeks F, Steunenberg TAH, de Boer F, Rubio-Gozalbo ME, Williams M, et al. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control. J Inherit Metab Dis 2017;40:695\u201302. https:\/\/doi.org\/10.1007\/s10545-017-0039-1.","DOI":"10.1007\/s10545-017-0039-1"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_010_w2aab3b7c12b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Shah AS, Wilson DP. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015;9:S20\u201328. https:\/\/doi.org\/10.1016\/j.jacl.2015.04.004.","DOI":"10.1016\/j.jacl.2015.04.004"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_011_w2aab3b7c12b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Blackett PR, Wilson DP, McNeal CJ. Secondary hypertriglyceridemia in children and adolescents. Clin Lipidol 2015;9:S29\u201340. https:\/\/doi.org\/10.1016\/j.jacl.2015.04.006.","DOI":"10.1016\/j.jacl.2015.04.006"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_012_w2aab3b7c12b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Leghi GE, Netting M, Muhlhausler BS. The short-term impact of dietary fat and sugar intake on breast milk composition: a clinical trial protocol. Nutr Health 2020;17:1\u20138. https:\/\/doi.org\/10.1177\/0260106019895367.","DOI":"10.1177\/0260106019895367"},{"key":"2023040101344807837_j_jpem-2019-0376_ref_013_w2aab3b7c12b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Shin YS. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin Pediatr Neurol 2006;13:115\u201320. https:\/\/doi.org\/10.1016\/j.spen.2006.06.007.","DOI":"10.1016\/j.spen.2006.06.007"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpem\/33\/6\/article-p803.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0376\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T20:52:19Z","timestamp":1680382339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0376\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,24]]},"published-print":{"date-parts":[[2020,5,26]]}},"alternative-id":["10.1515\/jpem-2019-0376"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2019-0376","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,21]]}}}